Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Psoriatic Arthritis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global psoriatic arthritis treatment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global psoriatic arthritis treatment market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug type, type, route of administration and distribution channel.

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others
     

Breakup by Type:

  • Prescription
  • OTC
     

Breakup by Route of Administration:

  • Injectable
  • Oral
  • Topical
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Type, Type, Route of Administration, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Psoriatic Arthritis Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Type
    6.1    NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Biologics
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Type
    7.1    Prescription
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    OTC
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Route of Administration
    8.1    Injectable
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Oral
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Amneal Pharmaceuticals LLC
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
        15.3.4    AstraZeneca plc
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Eisai Co. Ltd. 
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Eli Lilly and Company
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Johnson & Johnson Service ltd.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Novartis AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Samsung Biologics
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
        15.3.12    UCB S.A.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2020
Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2020
Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2020
Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2020
Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links